ANA Therapeutics $5mn seed round for COVID-19 treatment

By William Smith
ANA Therapeutics is a Silicon Valley, California-based biotech company developing a coronavirus vaccine...

ANA Therapeutics is a Silicon Valley, California-based biotech company developing a coronavirus vaccine. 

Founded earlier this year, the company has announced that the US Food and Drug Administration (FDA) has cleared its investigation into using niclosamide capsules as a potential COVID-19 treatment, allowing for human trials.

The company said it would perform the trial with 400 COVID-19 afflicted patients at 10 centres across the US. Specifically, these will be places experiencing a current surge such as Florida and Texas - with the aim being to entol the first patient in August.

The trial will assess niclosamide’s safety and its potential to alleviate symptoms. Niclosamide is a pre-existing drug chiefly used to treat tapeworm infections, but pre-clinical research conducted by the company has shown it to stop coronavirus from replicating.

The company yesterday announced a seed round raising $5mn from 11 investors, including the organisations SV Tech Ventures, SV Angel, SOSV, Refactor Capital and On Air Investments.

In a press release, ANA Co-Founder and CEO Akash Bakshi said: “Safe and effective antiviral therapies are critically needed to treat COVID-19 now and treatments will continue to be necessary even if a vaccine is developed. This will be the first U.S.- based clinical trial to determine the efficacy of niclosamide in COVID-19. Anticipating that niclosamide may prove to be effective against COVID-19, we are already laying plans to make the drug accessible to everyone.”

The company said that if proven to work, niclosamide had other benefits including being well tolerated and low-cost.

“As a start-up and unlike large life science companies, ANA Therapeutics has already moved at lightning speed to get niclosamide into clinical trials,” said Sam Altman, former president of Y Combinator and now the CEO of OpenAI. “I’m thrilled to invest in the team’s critically important mission to develop a safe, effective, and widely available treatment for COVID-19.”

Share

Featured Articles

World Mental Health Day: how parents can help stop bullying

How can parents help a child that is being bullied - or is a bully? Ready for World Mental Health Day, Dr. Monica Vermani explains what can be done

The Taiwan Excellence Award Winners on new technologies

Cypress Technology, Dacian Technology Material, Chroma ATE, Taiwan Advanced Nanotech & iDRC Chyng Hong Electronics are the Taiwan Excellence Award Winners

World Hepatitis Summit 2022 to support healthcare workers

The World Hepatitis Summit 2022 calls to prevent viral hepatitis as cases soar in children and healthcare workers struggle with the stigma

5 minutes with Yoni Nevo, CEO of Sweetch

Technology & AI

Canada’s telehealth support for Ukrainian healthcare workers

Technology & AI

How Contura’s hydrogel technology can help patients knees

Technology & AI